BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 38 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,534,080 | -48.1% | 67,223,000 | -57.4% | 1.74% | -37.0% |
| Q2 2023 | $124,241,221 | +0.1% | 157,723,000 | -5.8% | 2.76% | -5.4% |
| Q1 2023 | $124,078,968 | +75.8% | 167,448,000 | +6.8% | 2.91% | +106.1% |
| Q4 2022 | $70,578,450 | -24.5% | 156,841,000 | +0.4% | 1.41% | -13.0% |
| Q3 2022 | $93,497,000 | +20.9% | 156,141,000 | +11.8% | 1.62% | +17.2% |
| Q2 2022 | $77,333,000 | +28.6% | 139,641,000 | +39.3% | 1.39% | +27.3% |
| Q1 2022 | $60,134,000 | – | 100,224,000 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,655,000 | $82,515,000 | 3.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $131,952,000 | 2.77% |
| Aequim Alternative Investments LP | 22,000,000 | $36,397,000 | 2.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 66,696,000 | $110,306,000 | 0.93% |
| Polar Asset Management Partners Inc. | 50,000,000 | $82,872,000 | 0.82% |
| Castle Creek Arbitrage, LLC | 6,500,000 | $10,746,000 | 0.62% |
| Soleus Capital Management, L.P. | 1,950,000 | $3,216,000 | 0.58% |
| WESTWOOD HOLDINGS GROUP INC | 16,000,000 | $26,497,000 | 0.27% |
| Nicholas Investment Partners, LP | 2,100,000 | $3,464,000 | 0.24% |
| Magnetar Financial LLC | 14,500,000 | $24,028,000 | 0.23% |